Biomarkers for sensitivity of proliferative diseases to mTOR inhibitors

Details for Australian Patent Application No. 2004309499 (hide)

Owner Novartis AG

Inventors Maira, Sauveur-Michel; Boulay, Anne; Lane, Heidi; O'Reilly, Terence

Agent Davies Collison Cave

Pub. Number AU-A-2004309499

PCT Pub. Number WO2005/064343

Priority 60/531,700 22.12.03 US

Filing date 21 December 2004

Wipo publication date 14 July 2005

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/064343 Priority application(s): WO2005/064343

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309550-Method and arrangement for real-time betting with an off-line terminal

2004309490-Fluorometers